What is CRA International, Inc.'s earnings per share (EPS)?

CRA International, Inc. (CRAI) reported diluted earnings per share of $8.14 for fiscal year 2025. This represents a 20.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CRA International, Inc. (CRAI) Financials

CRAI

Trailing 12 months to July 4, 2026

Revenue $794.6M +11.5% YoY

Net Income $49.3M -12.9% YoY

EPS (Diluted) $8.14 FY2025 annual

Free Cash Flow -$27.7M -231.3% YoY

Market Cap $1.1B as of Oct 10, 2026

Price / Sales 1.4x on $794.6M revenue, trailing 12 months to July 4, 2026

Price / Earnings 22.5x on $49.3M net income, trailing 12 months to July 4, 2026

Price / Book 6.1x on $181.8M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 4, 2026 Reported Aug 6, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRAI SEC filings page.

CRA International, Inc. (CRAI) reported $794.6M in revenue over the twelve months to Jul 4, 2026, up 11.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRAI FY2025 2026-10-04

Revenue is scaling faster than costs, but cash conversion has weakened as receivables and short-term obligations rise.

Operating margin rose from 9.2% in FY2023 to 11.1% in FY2025 while revenue expanded, indicating better cost absorption rather than growth alone. In FY2025, operating cash flow was $22.4M against net income of $54.8M; that gap shows reported earnings were not arriving as cash at the same pace.

Receivables rose from $143M in FY2023 to $183M in FY2025, increasing the amount of customer-funded growth sitting on the balance sheet. Over the same span, operating cash flow fell from $60.1M to $22.4M, linking the weaker conversion to working-capital absorption rather than weaker accounting profitability.

Liquidity tightened: the current ratio fell from 1.1x in FY2024 to 0.9x in FY2025, meaning current obligations exceeded current assets at the latest year-end. Free cash flow was only $18.6M despite net income of $54.8M, while buybacks and dividends together exceeded that internally generated cash.

Financial Health Signals

Financial Health Score 53/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CRA International, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

CRA International, Inc. has an operating margin of 11.1%, meaning the company retains $11 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is up from 10.3% the prior year.

Growth

CRA International, Inc.'s revenue grew 9.3% year-over-year to $751.6M, a solid pace of expansion. This earns a growth score of 64/100.

Leverage

CRA International, Inc. has a moderate D/E ratio of 1.94. This balance of debt and equity financing earns a leverage score of 32/100.

Liquidity

CRA International, Inc.'s current ratio of 0.92 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

CRA International, Inc. has a free cash flow margin of 2.5%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

CRA International, Inc. earns a strong 25.7% return on equity (ROE), meaning it generates $26 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 89/100. This is up from 22.0% the prior year.

Altman Z-Score Safe

3.67

CRA International, Inc. scores 3.67, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

CRA International, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.41x

For every $1 of reported earnings, CRA International, Inc. generates $0.41 in operating cash flow ($22.4M OCF vs $54.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Safe

15.51x

CRA International, Inc. earns $15.51 in operating income for every $1 of interest expense ($83.1M vs $5.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$210.8M

YoY+12.8%

QoQ+4.9%

5Y CAGR+7.3%

10Y CAGR+9.8%

CRA International, Inc. generated $210.8M in revenue in Q2 2027. This represents an increase of 12.8% from the same quarter a year earlier. Against the prior quarter it is up 4.9%.

EBITDA

$26.8M

YoY+15.3%

QoQ+25.2%

5Y CAGR+7.0%

10Y CAGR+13.1%

CRA International, Inc.'s EBITDA was $26.8M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 15.3% from the same quarter a year earlier. Against the prior quarter it is up 25.2%.

Net Income

$13.5M

YoY+11.4%

QoQ+21.3%

5Y CAGR+3.2%

10Y CAGR+10.0%

CRA International, Inc. reported $13.5M in net income in Q2 2027. This represents an increase of 11.4% from the same quarter a year earlier. Against the prior quarter it is up 21.3%.

EPS (Diluted)

$2.10

YoY+17.3%

QoQ+24.3%

CRA International, Inc. earned $2.10 per diluted share (EPS) in Q2 2027. This represents an increase of 17.3% from the same quarter a year earlier. Against the prior quarter it is up 24.3%.

Cash & Balance Sheet

Free Cash Flow

-$6.1M

YoY-230.2%

QoQ+94.8%

CRA International, Inc. recorded an outflow of $6.1M in free cash flow in Q2 2027, representing a cash shortfall after capex. This represents a decrease of 230.2% from the same quarter a year earlier. Against the prior quarter it is up 94.8%.

Cash & Debt

$21.4M

YoY+10.3%

QoQ-34.0%

5Y CAGR+8.9%

10Y CAGR+5.8%

CRA International, Inc. held $21.4M in cash as of Q2 2027; long-term debt is not reported for that period.

Dividends Per Share

$0.57

YoY+16.3%

QoQ0.0%

CRA International, Inc. paid $0.57 per share in dividends in Q2 2027. This represents an increase of 16.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

YoY-4.7%

QoQ-2.9%

5Y CAGR-3.2%

10Y CAGR-2.6%

CRA International, Inc. had 6M shares outstanding in Q2 2027. This represents a decrease of 4.7% from the same quarter a year earlier. Against the prior quarter it is down 2.9%.

Margins & Returns

Gross Margin

29.4%

YoY-1.8pp

QoQ+1.6pp

5Y change+0.3pp

CRA International, Inc.'s gross margin was 29.4% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Operating Margin

11.2%

YoY+0.6pp

QoQ+2.2pp

5Y change+0.4pp

10Y change+4.3pp

CRA International, Inc.'s operating margin was 11.2% in Q2 2027, reflecting core business profitability. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Net Margin

6.4%

YoY-0.1pp

QoQ+0.9pp

5Y change-1.4pp

10Y change+0.1pp

CRA International, Inc.'s net profit margin was 6.4% in Q2 2027, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Return on Equity

7.4%

YoY+1.3pp

QoQ+1.8pp

5Y change+1.6pp

10Y change+4.9pp

CRA International, Inc.'s ROE was 7.4% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Capital Allocation

Share Buybacks

$27.8M

YoY-35.5%

QoQ+29.7%

5Y CAGR+1.9%

CRA International, Inc. spent $27.8M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 35.5% from the same quarter a year earlier. Against the prior quarter it is up 29.7%.

Capital Expenditures

$1.6M

YoY+38.4%

QoQ-37.9%

5Y CAGR+28.1%

10Y CAGR-0.2%

CRA International, Inc. invested $1.6M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 38.4% from the same quarter a year earlier. Against the prior quarter it is down 37.9%.

R&D Spending

Not reported for Q2 2027.

CRAI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRAI quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$794.6M	$751.6M+9.3%	$687.4M+10.2%	$624.0M+5.6%	$590.9M+4.4%	$565.9M+11.3%	$508.4M+12.6%	$451.4M+8.1%	$417.6M+12.9%	$370.1M+13.9%	$324.8M+7.0%	$303.6M-0.9%	$306.4M+10.0%	$278.4M+3.0%	$270.4M-11.4%	$305.2M
Cost of Revenue	$564.2M	$519.3M+8.2%	$479.9M+9.1%	$439.8M+7.2%	$410.1M+2.5%	$400.1M+7.9%	$370.7M+16.7%	$317.8M+9.9%	$289.2M+11.7%	$258.8M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$230.5M	$232.3M+12.0%	$207.5M+12.6%	$184.2M+1.9%	$180.8M+9.0%	$165.9M+20.5%	$137.7M+3.0%	$133.6M+4.0%	$128.5M+15.5%	$111.2M+14.2%	$97.4M+1.6%	$95.9M-3.7%	$99.6M+11.6%	$89.2M+1.3%	$88.0M-16.9%	$105.8M
SG&A Expenses	$137.2M	$135.0M+8.0%	$125.0M+8.6%	$115.1M+4.6%	$110.1M+13.1%	$97.4M+8.2%	$90.0M-3.8%	$93.6M+4.6%	$89.5M+3.5%	$86.5M+22.6%	$70.6M-2.6%	$72.4M+4.9%	$69.1M+7.5%	$64.2M-4.5%	$67.2M-6.3%	$71.8M
Operating Income	$79.4M	$83.1M+17.5%	$70.8M+22.9%	$57.5M-2.0%	$58.7M+5.4%	$55.7M+60.2%	$34.8M+18.6%	$29.3M+1.4%	$28.9M+83.6%	$15.8M-16.7%	$18.9M+52.6%	$12.4M-48.4%	$24.0M+29.8%	$18.5M+132.0%	-$57.8M-298.9%	$29.1M
EBITDA	N/A	$97.3M+18.0%	$82.4M+19.3%	$69.1M-2.3%	$70.7M+3.2%	$68.5M+43.8%	$47.6M+19.1%	$40.0M+2.7%	$38.9M+58.1%	$24.6M-8.1%	$26.8M+41.5%	$18.9M-37.9%	$30.5M+22.0%	$25.0M+148.1%	-$52.0M-252.1%	$34.2M
Interest Expense	$7.1M	$5.4M+21.3%	$4.4M+15.9%	$3.8M+108.8%	$1.8M+88.2%	$970K-20.2%	$1.2M-3.0%	$1.3M+93.8%	$647K+33.7%	$484K+3.2%	$469K-12.8%	$538K+24.8%	$431K-24.9%	$574K+91.3%	$300K-67.0%	$908K
Income Tax	$23.0M	$21.8M+11.2%	$19.6M+41.9%	$13.8M-9.1%	$15.2M+20.5%	$12.6M+38.2%	$9.1M+50.7%	$6.0M-6.4%	$6.5M-13.4%	$7.5M-2.5%	$7.7M+39.5%	$5.5M-44.6%	$9.9M+48.3%	$6.7M+229.0%	-$5.2M-146.5%	$11.1M
Net Income	$49.3M	$54.8M+17.3%	$46.7M+21.3%	$38.5M-11.7%	$43.6M+4.6%	$41.7M+70.2%	$24.5M+18.1%	$20.7M-7.8%	$22.5M+195.0%	$7.6M-40.8%	$12.9M+68.3%	$7.7M-42.9%	$13.4M+19.3%	$11.2M+121.3%	-$52.8M-411.9%	$16.9M
EPS (Basic)	N/A	$8.23+20.7%	$6.82+24.5%	$5.48-9.0%	$6.02+7.7%	$5.59+78.0%	$3.14+19.4%	$2.63-4.7%	$2.76+203.3%	$0.91-39.3%	$1.50+78.6%	$0.84-40.0%	$1.40+23.9%	$1.13+121.7%	-$5.21-425.6%	$1.60
EPS (Diluted)	—	$8.14+20.8%	$6.74+25.0%	$5.39-8.8%	$5.91+8.4%	$5.45+77.5%	$3.07+21.3%	$2.53-3.1%	$2.61+193.3%	$0.89-40.3%	$1.49+79.5%	$0.83-39.9%	$1.38+23.2%	$1.12+121.5%	-$5.21-431.8%	$1.57
Diluted Shares (Avg)	N/A	7M-2.8%	7M-3.0%	7M-3.2%	7M-3.5%	8M-4.1%	8M-2.7%	8M-4.7%	9M+0.9%	8M-1.2%	9M-6.5%	9M-7.1%	10M-2.7%	10M+0.1%	10M-5.3%	11M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Revenue	$210.8M+12.8%	$201.0M+10.5%	$197.0M+11.6%	$185.9M+10.8%	$186.9M+9.0%	$181.9M+5.9%	$176.4M+9.2%	$167.7M+13.7%
Cost of Revenue	$148.7M+15.7%	$145.0M+20.5%	$138.9M+15.3%	$131.5M+14.1%	$128.5M+2.6%	$120.4M+1.2%	$120.5M+7.0%	$115.2M+8.8%
Gross Profit	$62.1M+6.4%	$55.9M-9.0%	$58.0M+3.8%	$54.4M+3.5%	$58.3M+26.5%	$61.5M+16.2%	$55.9M+14.2%	$52.6M+26.2%
SG&A Expenses	$35.3M+0.5%	$34.5M+6.1%	$33.7M+7.7%	$33.7M+7.9%	$35.1M+9.6%	$32.5M+6.7%	$31.3M+7.9%	$31.3M+12.0%
Operating Income	$23.5M+19.3%	$18.0M-29.4%	$20.6M-3.8%	$17.2M-6.4%	$19.7M+74.8%	$25.5M+30.2%	$21.5M+25.1%	$18.4M+70.4%
EBITDA	$26.8M+15.3%	$21.4M-26.0%	$24.4M-1.1%	$20.7M-2.8%	$23.3M+65.0%	$29.0M+29.2%	$24.6M+23.5%	$21.3M+55.0%
Interest Expense	$3.0M+64.5%	$1.0M+135.7%	$1.4M+36.5%	$1.8M+20.1%	$1.8M+21.1%	$429K-7.5%	$1.0M+68.8%	$1.5M+42.1%
Income Tax	$6.6M+32.4%	$6.3M-5.7%	$5.4M-18.1%	$4.8M+3.4%	$5.0M+62.4%	$6.6M+24.8%	$6.6M+61.0%	$4.6M+138.3%
Net Income	$13.5M+11.4%	$11.1M-38.2%	$13.2M-12.2%	$11.5M+0.3%	$12.1M+85.4%	$18.0M+31.5%	$15.0M+31.0%	$11.4M+33.1%
EPS (Basic)	$2.13+17.7%	$1.71-35.5%	N/A	$1.74+3.6%	$1.81+88.5%	$2.65+34.5%	N/A	$1.68+37.7%
EPS (Diluted)	$2.10+17.3%	$1.69-35.5%	N/A	$1.73+3.6%	$1.79+90.4%	$2.62+34.4%	N/A	$1.67+38.0%
Diluted Shares (Avg)	6M-5.1%	7M-4.0%	N/A	7M-3.2%	7M-2.3%	7M-2.1%	N/A	7M-3.4%

Not reported in any period shown, so not listed: R&D Expenses.

CRAI Balance Sheet

CRAI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$628.9M+10.1%	$571.4M+3.3%	$553.2M+0.4%	$550.9M-0.8%	$555.4M-0.6%	$558.5M+4.7%	$533.2M+43.8%	$370.8M+2.5%	$361.8M+11.8%	$323.6M+3.2%	$313.7M+0.1%	$313.5M-2.1%	$320.3M+9.7%	$292.0M-21.5%	$372.1M
Current Assets	$303.1M+12.5%	$269.4M+1.5%	$265.5M+6.7%	$248.9M-0.2%	$249.3M+13.4%	$220.0M+19.5%	$184.1M+1.6%	$181.1M-1.7%	$184.3M+8.1%	$170.5M+21.1%	$140.8M-2.6%	$144.5M-11.3%	$163.0M-5.1%	$171.7M-9.6%	$189.9M
Cash & Equivalents	$18.2M-31.8%	$26.7M-41.4%	$45.6M+45.0%	$31.4M-52.4%	$66.1M+44.8%	$45.7M+78.2%	$25.6M-32.6%	$38.0M-29.6%	$54.0M+0.9%	$53.5M0.0%	$53.5M+11.1%	$48.2M-6.0%	$51.3M-7.6%	$55.5M-10.0%	$61.6M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$14.5M
Accounts Receivable	$183.3M+12.9%	$162.3M+13.7%	$142.7M-0.6%	$143.6M+22.8%	$117.0M+4.8%	$111.6M+3.5%	$107.8M+14.1%	$94.5M+18.4%	$79.8M+19.4%	$66.9M+9.8%	$60.9M+4.9%	$58.1M+0.4%	$57.9M+3.2%	$56.1M-18.0%	$68.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$94.7M+1.0%	$93.7M-0.3%	$94.0M+1.1%	$92.9M+4.5%	$88.9M-0.3%	$89.2M+0.8%	$88.5M+0.3%	$88.2M-0.9%	$89.0M+19.0%	$74.8M-2.9%	$77.0M-6.5%	$82.3M+0.9%	$81.6M+15.3%	$70.8M-49.7%	$140.7M
Total Liabilities	$415.3M+15.6%	$359.4M+5.4%	$341.1M+0.4%	$339.8M-2.8%	$349.5M0.0%	$349.5M+4.2%	$335.5M+92.4%	$174.4M+12.6%	$154.8M+33.0%	$116.4M+14.2%	$102.0M+2.6%	$99.4M+3.0%	$96.5M+19.5%	$80.7M-22.7%	$104.5M
Current Liabilities	$330.0M+31.3%	$251.3M+6.4%	$236.1M+8.7%	$217.1M+1.9%	$213.1M+6.5%	$200.1M+16.8%	$171.4M+20.3%	$142.5M+16.8%	$122.0M+29.6%	$94.1M+8.8%	$86.5M-2.1%	$88.3M+0.4%	$88.0M+27.1%	$69.2M-15.9%	$82.3M
Non-Current Liabilities	$85.2M-21.1%	$108.1M+2.9%	$105.0M-14.4%	$122.6M-10.1%	$136.4M-8.7%	$149.4M-9.0%	$164.1M+414.7%	$31.9M-2.1%	$32.5M+50.3%	$21.7M+33.8%	$16.2M+54.3%	$10.5M+22.8%	$8.5M-25.8%	$11.5M-48.2%	$22.2M
Total Equity	$213.6M+0.7%	$212.1M0.0%	$212.1M+0.4%	$211.2M+2.6%	$205.8M-1.5%	$209.0M+5.7%	$197.8M+0.7%	$196.5M-5.0%	$206.9M-0.2%	$207.2M-2.1%	$211.8M-1.1%	$214.1M-4.3%	$223.8M+5.9%	$211.3M-21.0%	$267.6M
Retained Earnings	$221.1M-2.0%	$225.5M+0.5%	$224.3M0.0%	$224.4M+4.0%	$215.8M-0.6%	$217.0M+8.4%	$200.2M+7.5%	$186.2M+9.9%	$169.4M+1.5%	$166.9M+7.5%	$155.3M+5.2%	$147.6M+10.2%	$134.0M+9.3%	$122.6M-30.2%	$175.6M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Total Assets	$678.5M+11.8%	$662.4M+12.2%	$628.9M+10.1%	$629.0M+8.0%	$606.8M+11.1%	$590.4M+6.9%	$571.4M+3.3%	$582.3M+8.0%
Current Assets	$339.0M+15.6%	$316.5M+13.8%	$303.1M+12.5%	$305.6M+7.0%	$293.1M+8.1%	$278.1M+1.0%	$269.4M+1.5%	$285.5M+14.8%
Cash & Equivalents	$21.4M+10.3%	$32.5M+26.9%	$18.2M-31.8%	$22.5M-8.1%	$19.4M-21.1%	$25.6M-31.0%	$26.7M-41.4%	$24.5M-11.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$168.1M+5.2%	$141.0M+0.5%	$183.3M+12.9%	$151.9M-0.2%	$159.7M+14.0%	$140.3M+0.9%	$162.3M+13.7%	$152.1M+21.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$94.6M-0.4%	$94.5M+0.4%	$94.7M+1.0%	$94.6M+0.1%	$94.9M+1.2%	$94.1M+0.3%	$93.7M-0.3%	$94.6M+1.2%
Total Liabilities	$496.6M+21.2%	$464.0M+27.8%	$415.3M+15.6%	$427.4M+13.1%	$409.8M+15.7%	$363.1M+6.6%	$359.4M+5.4%	$377.8M+14.1%
Current Liabilities	$415.2M+30.8%	$380.8M+40.8%	$330.0M+31.3%	$338.6M+26.2%	$317.3M+25.6%	$270.5M+14.2%	$251.3M+6.4%	$268.3M+19.6%
Non-Current Liabilities	$81.4M-11.9%	$83.2M-10.2%	$85.2M-21.1%	$88.8M-19.0%	$92.5M-9.0%	$92.6M-10.9%	$108.1M+2.9%	$109.6M+2.6%
Total Equity	$181.8M-7.7%	$198.4M-12.7%	$213.6M+0.7%	$201.7M-1.4%	$197.0M+2.7%	$227.3M+7.3%	$212.1M0.0%	$204.5M-1.7%
Retained Earnings	$192.2M-6.9%	$209.2M-12.8%	$221.1M-2.0%	$211.7M-1.1%	$206.5M+0.6%	$240.0M+6.6%	$225.5M+0.5%	$213.9M-3.3%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

CRAI Cash Flow Statement

CRAI quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$21.7M	$22.4M-54.9%	$49.7M-17.2%	$60.1M+139.1%	$25.1M-66.8%	$75.7M+38.5%	$54.7M+96.4%	$27.8M-23.1%	$36.2M-21.1%	$45.9M-4.8%	$48.2M+135.8%	$20.4M-32.3%	$30.1M+63.4%	$18.4M+316.4%	-$8.5M-128.4%	$30.0M
Depreciation & Amortization	N/A	$14.1M+21.1%	$11.7M+1.0%	$11.6M-3.6%	$12.0M-6.0%	$12.8M-0.6%	$12.8M+20.6%	$10.6M+6.5%	$10.0M+12.8%	$8.9M+12.5%	$7.9M+20.4%	$6.5M+1.6%	$6.4M-0.3%	$6.5M+10.6%	$5.8M+14.5%	$5.1M
Stock-Based Compensation	N/A	$5.9M+10.9%	$5.3M+20.3%	$4.4M-7.8%	$4.8M+16.8%	$4.1M+26.3%	$3.2M-6.5%	$3.5M-28.2%	$4.8M-27.2%	$6.6M-3.7%	$6.9M+18.6%	$5.8M+3.1%	$5.6M+85.1%	$3.0M-38.6%	$4.9M-14.2%	$5.8M
Capital Expenditures	$6.0M	$3.9M-76.7%	$16.6M+602.6%	$2.4M-37.9%	$3.8M+45.4%	$2.6M-84.7%	$17.1M+2.4%	$16.7M+8.1%	$15.4M+58.3%	$9.8M-25.1%	$13.0M-27.5%	$18.0M+328.8%	$4.2M+48.9%	$2.8M+3.1%	$2.7M-66.9%	$8.2M
Free Cash Flow	-$27.7M	$18.6M-44.0%	$33.1M-42.6%	$57.7M+170.8%	$21.3M-70.8%	$73.1M+94.5%	$37.6M+237.3%	$11.1M-46.3%	$20.7M-42.5%	$36.1M+2.7%	$35.1M+1334.9%	$2.4M-90.6%	$26.0M+66.1%	$15.6M+238.9%	-$11.3M-151.7%	$21.8M
Investing Cash Flow	-$6.0M	-$3.9M+78.7%	-$18.1M-515.8%	-$2.9M+83.8%	-$18.2M-592.5%	-$2.6M+84.7%	-$17.1M-2.4%	-$16.7M-8.1%	-$15.4M+39.8%	-$25.7M-115.3%	-$11.9M+27.7%	-$16.5M	N/A	N/A	N/A	N/A
Financing Cash Flow	$29.1M	-$29.8M+38.9%	-$48.9M-9.8%	-$44.5M-14.2%	-$39.0M+25.1%	-$52.0M-166.6%	-$19.5M+18.1%	-$23.8M+33.4%	-$35.7M-63.6%	-$21.9M-13.9%	-$19.2M-47.1%	-$13.0M	N/A	N/A	N/A	N/A
Dividends Paid	$14.4M	$13.8M+12.4%	$12.3M+13.8%	$10.8M+12.8%	$9.6M+15.6%	$8.3M+10.5%	$7.5M+10.6%	$6.8M+17.3%	$5.8M+17.1%	$4.9M+323.8%	$1.2M	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$53.3M	$47.1M+41.4%	$33.3M+6.1%	$31.4M+13.7%	$27.6M-38.6%	$45.0M+236.4%	$13.4M-26.0%	$18.1M-35.2%	$27.9M+42.8%	$19.5M+1.1%	$19.3M+50.8%	$12.8M-49.8%	$25.5M+1064.0%	$2.2M-75.8%	$9.1M+0.1%	$9.1M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Operating Cash Flow	-$4.4M-175.6%	-$113.9M-42.4%	$60.0M-24.4%	$36.5M+15.7%	$5.9M+223.9%	-$80.0M-26.8%	$79.4M+32.2%	$31.6M-51.4%
Depreciation & Amortization	$3.3M-7.1%	$3.4M-0.6%	$3.7M+17.0%	$3.5M+20.2%	$3.5M+25.6%	$3.4M+22.2%	$3.2M+13.3%	$2.9M-1.6%
Stock-Based Compensation	N/A	$1.4M-1.7%	N/A	N/A	N/A	$1.4M+33.8%	N/A	N/A
Capital Expenditures	$1.6M+38.4%	$2.6M+172.0%	$1.1M-90.0%	$650K-78.2%	$1.2M-48.7%	$974K+33.4%	$10.6M+2858.4%	$3.0M+311.3%
Free Cash Flow	-$6.1M-230.2%	-$116.5M-43.9%	$59.0M-14.3%	$35.9M+25.5%	$4.7M+1016.1%	-$81.0M-26.9%	$68.8M+15.2%	$28.6M-55.5%
Investing Cash Flow	-$1.6M-38.4%	-$2.6M-172.0%	-$1.1M+90.0%	-$650K+78.2%	-$1.2M+68.8%	-$974K-33.4%	-$10.6M-2858.4%	-$3.0M-307.4%
Financing Cash Flow	-$5.2M+56.6%	$131.3M+66.1%	-$64.7M-0.2%	-$32.3M-7.9%	-$11.9M-14.7%	$79.1M+41.0%	-$64.6M-50.0%	-$29.9M+40.8%
Dividends Paid	$3.6M+7.8%	$3.8M+9.1%	$3.7M+8.2%	$3.2M+12.7%	$3.4M+16.2%	$3.5M+13.4%	$3.5M+13.7%	$2.9M+13.0%
Share Buybacks	$27.8M-35.5%	$21.5M	$0	$4.0M	$43.1M+79.0%	$0-100.0%	$0-100.0%	$0

CRAI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRAI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	30.9%+0.7pp	30.2%+0.7pp	29.5%-1.1pp	30.6%+1.3pp	29.3%+2.2pp	27.1%-2.5pp	29.6%-1.2pp	30.8%+0.7pp	30.1%+0.1pp	30.0%-1.6pp	31.6%-0.9pp	32.5%+0.5pp	32.0%-0.5pp	32.6%-2.1pp	34.7%
Operating Margin	11.1%+0.8pp	10.3%+1.1pp	9.2%-0.7pp	9.9%+0.1pp	9.8%+3.0pp	6.8%+0.3pp	6.5%-0.4pp	6.9%+2.7pp	4.3%-1.6pp	5.8%+1.7pp	4.1%-3.8pp	7.8%+1.2pp	6.7%+28.0pp	-21.4%-30.9pp	9.5%
Net Margin	7.3%+0.5pp	6.8%+0.6pp	6.2%-1.2pp	7.4%0.0pp	7.4%+2.6pp	4.8%+0.2pp	4.6%-0.8pp	5.4%+3.3pp	2.1%-1.9pp	4.0%+1.4pp	2.5%-1.9pp	4.4%+0.3pp	4.0%+23.6pp	-19.5%-25.1pp	5.5%
Return on Equity	25.7%+3.6pp	22.0%+3.9pp	18.1%-2.5pp	20.6%+0.4pp	20.3%+8.5pp	11.7%+1.2pp	10.5%-1.0pp	11.5%+7.8pp	3.7%-2.5pp	6.2%+2.6pp	3.6%-2.6pp	6.3%+1.2pp	5.0%+30.0pp	-25.0%-31.3pp	6.3%
Return on Assets	8.7%+0.5pp	8.2%+1.2pp	7.0%-1.0pp	7.9%+0.4pp	7.5%+3.1pp	4.4%+0.5pp	3.9%-2.2pp	6.1%+4.0pp	2.1%-1.9pp	4.0%+1.5pp	2.4%-1.8pp	4.3%+0.8pp	3.5%+21.6pp	-18.1%-22.6pp	4.5%
Current Ratio	0.92-0.2x	1.07-0.1x	1.120.0x	1.150.0x	1.17+0.1x	1.100.0x	1.07-0.2x	1.27-0.2x	1.51-0.3x	1.81+0.2x	1.630.0x	1.64-0.2x	1.85-0.6x	2.48+0.2x	2.31
Debt-to-Equity	1.94+0.2x	1.69+0.1x	1.610.0x	1.61-0.1x	1.700.0x	1.670.0x	1.70+0.8x	0.89+0.1x	0.75+0.2x	0.56+0.1x	0.480.0x	0.460.0x	0.430.0x	0.380.0x	0.39
Asset Turnover	1.200.0x	1.20+0.1x	1.13+0.1x	1.07+0.1x	1.02+0.1x	0.91+0.1x	0.85-0.3x	1.13+0.1x	1.020.0x	1.000.0x	0.970.0x	0.98+0.1x	0.87-0.1x	0.93+0.1x	0.82
FCF Margin	2.5%-2.4pp	4.8%-4.4pp	9.3%+5.6pp	3.6%-9.3pp	12.9%+5.5pp	7.4%+4.9pp	2.5%-2.5pp	5.0%-4.8pp	9.8%-1.1pp	10.8%+10.0pp	0.8%-7.7pp	8.5%+2.9pp	5.6%+9.8pp	-4.2%-11.3pp	7.1%

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Gross Margin	29.4%-1.8pp	27.8%-6.0pp	29.5%-2.2pp	29.3%-2.1pp	31.2%+4.3pp	33.8%+3.0pp	31.7%+1.4pp	31.3%+3.1pp
Operating Margin	11.2%+0.6pp	9.0%-5.1pp	10.5%-1.7pp	9.3%-1.7pp	10.6%+4.0pp	14.1%+2.6pp	12.2%+1.6pp	11.0%+3.7pp
Net Margin	6.4%-0.1pp	5.5%-4.4pp	6.7%-1.8pp	6.2%-0.6pp	6.5%+2.7pp	9.9%+1.9pp	8.5%+1.4pp	6.8%+1.0pp
Return on Equity	7.4%+1.3pp	5.6%-2.3pp	6.2%-0.9pp	5.7%+0.1pp	6.2%+2.7pp	7.9%+1.5pp	7.1%+1.7pp	5.6%+1.5pp
Return on Assets	2.0%0.0pp	1.7%-1.4pp	2.1%-0.5pp	1.8%-0.1pp	2.0%+0.8pp	3.0%+0.6pp	2.6%+0.6pp	2.0%+0.4pp
Current Ratio	0.82-0.1x	0.83-0.2x	0.92-0.2x	0.90-0.2x	0.92-0.1x	1.03-0.1x	1.07-0.1x	1.060.0x
Debt-to-Equity	2.73+0.7x	2.34+0.7x	1.94+0.2x	2.12+0.3x	2.08+0.2x	1.600.0x	1.69+0.1x	1.85+0.3x
Asset Turnover	0.310.0x	0.300.0x	0.310.0x	0.300.0x	0.310.0x	0.310.0x	0.310.0x	0.290.0x
FCF Margin	-2.9%-5.4pp	-58.0%-13.5pp	29.9%-9.1pp	19.3%+2.3pp	2.5%+2.8pp	-44.5%-7.4pp	39.0%+2.0pp	17.1%-26.5pp

Note: The current ratio is below 1.0 (0.92), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CRA International, Inc. CRAI	FY2025	$751.6M	$54.8M	7.3%	$1.1B	53/100
ICF International, Inc. ICFI	FY2025	$1.9B	$92.0M	4.9%	$1.6B	47/100
Diginex Limited DGNX	FY2025	$2.0M	-$5.2M	N/A	$37.0M	16/100
SBC Medical Group Holdings Incorporated SBC	FY2025	$173.6M	$51.0M	29.4%	$557.4M	77/100
Huron Consulting Group Inc. HURN	FY2025	$1.7B	$105.0M	6.2%	$2.7B	56/100
FTI Consulting, Inc. FCN	FY2025	$3.8B	$270.9M	7.1%	$3.8B	62/100

Where CRA International, Inc. Ranks

Frequently Asked Questions

What is CRA International, Inc.'s annual revenue?

CRA International, Inc. (CRAI) reported $751.6M in total revenue for fiscal year 2025. This represents a 9.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CRA International, Inc.'s revenue growing?

CRA International, Inc. (CRAI) revenue grew by 9.3% year-over-year, from $687.4M to $751.6M in fiscal year 2025.

Is CRA International, Inc. profitable?

Yes, CRA International, Inc. (CRAI) reported a net income of $54.8M in fiscal year 2025, with a net profit margin of 7.3%.

What is CRA International, Inc.'s EBITDA?

CRA International, Inc. (CRAI) had EBITDA of $97.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is CRA International, Inc.'s gross margin?

CRA International, Inc. (CRAI) had a gross margin of 30.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CRA International, Inc.'s operating margin?

CRA International, Inc. (CRAI) had an operating margin of 11.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CRA International, Inc.'s net profit margin?

CRA International, Inc. (CRAI) had a net profit margin of 7.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does CRA International, Inc. pay dividends?

Yes, CRA International, Inc. (CRAI) paid $2.04 per share in dividends during fiscal year 2025.

What is CRA International, Inc.'s return on equity (ROE)?

CRA International, Inc. (CRAI) has a return on equity of 25.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CRA International, Inc.'s free cash flow?

CRA International, Inc. (CRAI) generated $18.6M in free cash flow during fiscal year 2025. This represents a -44.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CRA International, Inc.'s operating cash flow?

CRA International, Inc. (CRAI) generated $22.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CRA International, Inc.'s total assets?

CRA International, Inc. (CRAI) had $628.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CRA International, Inc.'s capital expenditures?

CRA International, Inc. (CRAI) invested $3.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does CRA International, Inc. buy back shares?

Yes, CRA International, Inc. (CRAI) spent $47.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does CRA International, Inc. have outstanding?

CRA International, Inc. (CRAI) had 7M shares outstanding as of fiscal year 2025.

What is CRA International, Inc.'s current ratio?

CRA International, Inc. (CRAI) had a current ratio of 0.92 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is CRA International, Inc.'s debt-to-equity ratio?

CRA International, Inc. (CRAI) had a debt-to-equity ratio of 1.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CRA International, Inc.'s return on assets (ROA)?

CRA International, Inc. (CRAI) had a return on assets of 8.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CRA International, Inc.'s P/E ratio?

CRA International, Inc. (CRAI) trades at 22.5x earnings, its market capitalization divided by net income of $49.3M net income, trailing 12 months to July 4, 2026. The market capitalization is $1.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CRA International, Inc.'s price-to-sales ratio?

CRA International, Inc. (CRAI) trades at 1.4x sales, its market capitalization divided by revenue of $794.6M revenue, trailing 12 months to July 4, 2026. The market capitalization is $1.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CRA International, Inc.'s Altman Z-Score?

CRA International, Inc. (CRAI) has an Altman Z-Score of 3.67, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is CRA International, Inc.'s Piotroski F-Score?

CRA International, Inc. (CRAI) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CRA International, Inc.'s earnings high quality?

CRA International, Inc. (CRAI) has an earnings quality ratio of 0.41x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CRA International, Inc. cover its interest payments?

CRA International, Inc. (CRAI) has an interest coverage ratio of 15.51x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is CRA International, Inc.?

CRA International, Inc. (CRAI) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.